The Innovation Illusion: Why Biopharma Breakthroughs Aren't Moving The Market

The 2025 Global Biopharma Index reveals a widening gap between scientific innovation and commercial performance. Despite strong growth in revenue and technological breakthroughs, nearly half of biopharma firms are falling short of profitability and market share goals. This white paper analyzes six critical pillars—supply chain resilience, talent, R&D, manufacturing agility, policy, and sustainability—across 22 countries, highlighting where ecosystems are enabling success and where they’re holding it back. Key findings show that digital maturity, strategic collaboration, and policy clarity are strong predictors of high-growth performance. Learn about five actionable recommendations to futureproof the industry, from embedding sustainability into core operations to strengthening regulatory engagement.

Uncover where biopharma is thriving and where urgent action is needed.